NASDAQ:CLVS
Delisted
Clovis Oncology Stock News
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Why Clovis Oncology Zoomed 30% Higher Today
07:09pm, Monday, 12'th Sep 2022
The biotech delivers some highly encouraging news on the clinical front.
Penny Stocks To Buy: 3 Short Squeeze Stocks To Watch Right Now
05:38pm, Monday, 12'th Sep 2022 PennyStocks
Short Squeeze Penny Stocks To Watch
The post Penny Stocks To Buy: 3 Short Squeeze Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
04:45pm, Monday, 12'th Sep 2022 Benzinga
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Phar
Penny Stocks To Buy: 3 Short Squeeze Stocks To Watch Right Now
01:38pm, Monday, 12'th Sep 2022
Short Squeeze Penny Stocks To Watch The post Penny Stocks To Buy: 3 Short Squeeze Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket
10:30am, Monday, 12'th Sep 2022 Benzinga
Gainers
Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.
Quhuo Limited (NASDAQ: QH) shares rose 24% to $3.41 in pre-market trading. Quhuo filed req
Why Is Clovis Oncology (CLVS) Stock Up 11% Today?
09:33am, Monday, 12'th Sep 2022
Source: rafapress / Shutterstock.com Clovis Oncology (NASDAQ: CLVS ) stock is rising higher on Monday following the release of results from a Phase 3 clinical trial. That trail covers Rubraca as a mon
Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound?
03:30pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clovis (CLVS) Down 12.6% Since Last Earnings Report: Can It Rebound?
12:48pm, Wednesday, 07'th Sep 2022
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock?
Why Clovis Oncology Stock Is Sinking Today
05:37pm, Monday, 08'th Aug 2022 The Motley Fool
The biotech's Q2 financial results are concerning investors today.
Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss
04:42pm, Monday, 08'th Aug 2022 Zacks Investment Research
Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts. CLVS faces the risk of a cash crunch.
Clovis (CLVS) Q2 Loss Wider Than Expected, Revenues Miss
02:18pm, Monday, 08'th Aug 2022
Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts.
Why Clovis Oncology Stock Is Sinking Today
01:37pm, Monday, 08'th Aug 2022
The biotech's Q2 financial results are concerning investors today.
Clovis Oncology (CLVS) Reports Q2 Loss, Misses Revenue Estimates
01:15pm, Monday, 08'th Aug 2022 Zacks Investment Research
Clovis (CLVS) delivered earnings and revenue surprises of -2.38% and 15.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Clovis Oncology (CLVS) Stock Down 10% Today?
01:11pm, Monday, 08'th Aug 2022
Clovis Oncology (NASDAQ: CLVS ) stock is down more than 10% today after posting its second-quarter financial results. The biopharmaceutical company missed on revenue and profits, leading the way for t
Clovis Oncology, Inc. (CLVS) CEO Patrick Mahaffy on Q2 2022 Results - Earnings Call Transcript
12:42pm, Monday, 08'th Aug 2022
Clovis Oncology, Inc. (NASDAQ:CLVS ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Anna Sussman - VP, IR Patrick Mahaffy - Co-Founder, CEO, President & Executive Dire
